EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

MicroRNAs in Hepatocellular Carcinoma Pathogenesis: Insights into Mechanisms and Therapeutic Opportunities

Khadijeh Mahboobnia iD, Dianne J Beveridge iD, George C Yeoh, Tasnuva D Kabir, Peter J Leedman

International Journal of Molecular Sciences · 29.08.2024 · 25 (17) · 9393

DOI: 10.3390/ijms25179393 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 29.08.2024. Verfasst von Khadijeh Mahboobnia und 4 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory for Cancer Medicine, Harry Perkins Institute of Medical Research, QEII Medical Centre, Perth, WA 6009, Australia. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Neoplasms, MicroRNAs, Gene Expression Regulation, Neoplastic. Die Arbeit wurde bisher 24-mal zitiert (Crossref) und nennt 449 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Cancer Council NSW.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Hepatocellular carcinoma (HCC) presents a significant global health burden, with alarming statistics revealing its rising incidence and high mortality rates. Despite advances in medical care, HCC treatment remains challenging due to late-stage diagnosis, limited effective therapeutic options, tumor heterogeneity, and drug resistance. MicroRNAs (miRNAs) have attracted substantial attention as key regulators of HCC pathogenesis. These small non-coding RNA molecules play pivotal roles in modulating gene expression, implicated in various cellular processes relevant to cancer development. Understanding the intricate network of miRNA-mediated molecular pathways in HCC is essential for unraveling the complex mechanisms underlying hepatocarcinogenesis and developing novel therapeutic approaches. This manuscript aims to provide a comprehensive review of recent experimental and clinical discoveries regarding the complex role of miRNAs in influencing the key hallmarks of HCC, as well as their promising clinical utility as potential therapeutic targets.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, HepatocellularLiver NeoplasmsMicroRNAsGene Expression Regulation, NeoplasticHumansAnimalsBiomarkers, Tumor

Stichwörter der Autor:innen

delivery systemsdrug resistancehepatocellular carcinomamicroRNAstargeted therapytumor heterogeneity

Substanzen

MicroRNAsBiomarkers, Tumor

Autor:innen und Institutionen

  • Laboratory for Cancer Medicine, Harry Perkins Institute of Medical Research, QEII Medical Centre, Perth, WA 6009, Australia.
  • Centre for Medical Research, The University of Western Australia, Perth, WA 6009, Australia.
  • School of Molecular Sciences, The University of Western Australia, Perth, WA 6009, Australia.

ORCID-Profile: Khadijeh Mahboobnia, Dianne J Beveridge

Förderung

  • Cancer Council NSW

Zitieren

APA

Mahboobnia, K., Beveridge, D. J., Yeoh, G. C., Kabir, T. D., & Leedman, P. J. (2024). MicroRNAs in Hepatocellular Carcinoma Pathogenesis: Insights into Mechanisms and Therapeutic Opportunities. International Journal of Molecular Sciences, 25(17), 9393. https://doi.org/10.3390/ijms25179393

Vancouver

Mahboobnia K, Beveridge DJ, Yeoh GC, Kabir TD, Leedman PJ. MicroRNAs in Hepatocellular Carcinoma Pathogenesis: Insights into Mechanisms and Therapeutic Opportunities. International Journal of Molecular Sciences. 2024;25(17):9393. doi:10.3390/ijms25179393

BibTeX
@article{Mahboobnia2024,
  author = {Mahboobnia, Khadijeh and Beveridge, Dianne J and Yeoh, George C and Kabir, Tasnuva D and Leedman, Peter J},
  title = {MicroRNAs in Hepatocellular Carcinoma Pathogenesis: Insights into Mechanisms and Therapeutic Opportunities},
  journal = {International Journal of Molecular Sciences},
  year = {2024},
  volume = {25},
  number = {17},
  pages = {9393},
  doi = {10.3390/ijms25179393}
}
Kostenlos starten →